Please login to the form below
Opioid
This page shows the latest Opioid news and features for those working in and with pharma, biotech and healthcare.
Eli Lilly signs agreement worth up to $600m for Confo Therapeutics' non-opioid pain candidate
Currently in phase 1 clinical development, CFTX-1554 represents a non-opioid approach to treating neuropathic pain, a condition caused by damage to the nerves outside the brain and spinal cord. ... The condition can be very severe, and existing treatments
Latest news
-
FDA external report recommends actions to address US opioid crisis
also related to opioid prescribing issues – along with key regulatory policies and decisions. ... Opioids are commonly used for the treatment of pain and include medicines such as morphine, fentanyl and tramadol.
-
FDA panel backs over-the-counter use of Emergent BioSolutions’ Narcan
The nasal spray works by blocking the effects of an opioid overdose if administered in time. ... Opioids are commonly used for the treatment of pain and include medicines such as morphine, fentanyl and tramadol.
-
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
According to the Centers for Disease Control and Prevention, nearly 500, 000 people have died from an overdose involving any opioid, including prescription and illicit opioids, between 1999 and 2019. ... Throughout the legal proceedings related to the
-
A day late and a dollar short
And you’ll fondly remember that McKinsey has a history of questionable healthcare consulting, as evidenced by its role in fuelling the opioid scandal for which it is being sued. ... And, of course, juxtaposed with its role in helping fuel the opioid
-
AbbVie’s Allergan reaches proposed $2.37bn agreement to settle US opioid lawsuits
According to the Centers for Disease Control and Prevention (CDC), nearly 500, 000 people have died from an overdose involving any opioid, including prescription and illicit opioids, between 1999 and 2019. ... Both settlements remain contingent on
More from news
Approximately 42 fully matching, plus 154 partially matching documents found.
Latest Intelligence
-
Impact That Matters
Using portraits and quotes from people who use drugs, the campaign urges the community to carry naloxone – a life-saving opioid overdose reversal drug.
-
20 for 2020 – Five pharma leaders to watch in 2020
Hahn is taking over as the FDA is being thrust into the spotlight on a number of issues, including how to deal with medicine prices, the opioid epidemic, hastening access to
-
20 for 2020 – Five pharma companies to watch
year. We’re talking about the lawsuits J&J is facing claiming damages as a result of using its products, including opioid painkillers, Baby Powder talc and its schizophrenia drug Risperdal ... epidemic in opioid abuse and overdose-related deaths in the
-
Will biosimilars ever catch on in the US?
First-to-market generics included medicines for opioid overdose, pulmonary arterial hypertension, breast cancer, seizures, depression and various infections.
-
The transatlantic opioid crisis
There’s some evidence to suggest similar transgressions in the UK with opioids. ... In another case, a single GP had ten patients addicted to synthetic opioids.
More from intelligence
Approximately 2 fully matching, plus 26 partially matching documents found.
Latest appointments
-
New faces at Merus, Rubius Therapeutics and Titan Pharmaceuticals
DeVarney joined Titan over ten years ago, and has lead the development of its opioid addiction treatment Probuphine.
-
Egalet appoints Stan Musial as CFO
s pipeline of abuse-deterrent opioids are nearing phase III.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
THE HIDDEN LIFESAVERS: overdose prevention campaign launches nationwide
But, over recent years, opioid overdose deaths have been steadily rising in the UK. ... 2, 644 people lost their lives to opioid-related overdoses in the UK in 2018.
-
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD) conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018. ... The two-day event succeeded in delivering what IOTOD is well known for: expert
-
IOTOD: Improving Opioid Dependence Outcomes
IOTOD’s future. The IOTOD educational initiative perpetually aims to provide the most up-to-date information in the field of opioid addiction. ... in opioid addiction and gain valuable insight on some of the most controversial topics in the field.
-
"Legal highs" ruling leaves illegal labs laughing
So we are acutely aware of the devastation caused by the opioid epidemic in the US, and the criticism aimed at Purdue, the maker of OxyContin. ... We have also pitched for agents designed to treat opioid overdose and alcohol abuse.
-
Research Partnership has published a new Living with Chronic Pain market report for 2016
At least 60% of the patients surveyed are currently prescribed long acting opioids (LAOs).
More from PMHub
Approximately 1 fully matching, plus 5 partially matching documents found.
Subscribe to our email news alerts
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Sanofi's frexalimab shows promise in relapsing forms of MS
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
- Amgen reports positive results for Otezla in psoriatic arthritis
- Supply chain challenges in 2023
- Whitepaper: Closing the gap with compelling healthcare communications
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- Supporting the most vulnerable: why pharma should get behind the NHS’ healthcare equity campaign
- Healing the Healers
- The (inevitable) digital transformation of Medical Affairs
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
No results were found
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Whitepaper: Closing the gap with compelling healthcare communications
- Want to learn how to close the distance between a person’s current health and their healthiest possible self?...
- Healing the Healers
- Because if we do not heal the healers, who is going to heal us?...
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’...
